View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Respiratory Infections News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 12, 2023
3 min read
Save

Odds of patients with MIS-C experiencing shock have fallen

Odds of patients with MIS-C experiencing shock have fallen

Hospitalized patients with multisystem inflammatory syndrome in children — or MIS-C —are far more likely to experience shock than those hospitalized with Kawasaki disease, according to a study.

SPONSORED CONTENT
October 12, 2023
2 min read
Save

COVID-19 mRNA booster provides additional protection, most beneficial for older adults

COVID-19 mRNA booster provides additional protection, most beneficial for older adults

BOSTON — Boosting with mRNA-1273 provided additional COVID-19 protection during the delta and omicron waves, and especially among older adults, according to data from the phase 3 coronavirus efficacy (COVE) trial presented at IDWeek.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
October 12, 2023
2 min read
Save

Wastewater signals match spikes in clinical cases of COVID-19, flu, RSV

Wastewater signals match spikes in clinical cases of COVID-19, flu, RSV

BOSTON — Expanded use of wastewater surveillance confirmed spikes in clinical cases of COVID-19, influenza and respiratory syncytial virus in one of Canada’s largest cities, according to study findings presented at IDWeek.

SPONSORED CONTENT
October 11, 2023
2 min read
Save

Intranasal COVID-19 vaccine candidate generates robust immune response

Intranasal COVID-19 vaccine candidate generates robust immune response

BOSTON — Two doses of an experimental live-attenuated intranasal COVID-19 vaccine generated a robust immune response in a phase 1 trial, researchers reported.

SPONSORED CONTENT
October 11, 2023
2 min read
Save

Maternal RSV vaccine could significantly reduce clinical visits, costs

Maternal RSV vaccine could significantly reduce clinical visits, costs

Pfizer’s maternal vaccine against respiratory syncytial virus could significantly decrease clinical visits among infants and save more than $800 million in overall costs, according to a study presented at IDWeek.

SPONSORED CONTENT
October 10, 2023
3 min read
Save

Study: Maternal pertussis vaccination prevents most infant infections

Study: Maternal pertussis vaccination prevents most infant infections

Maternal pertussis vaccination resulted in a 66% decrease in pertussis among infants through age 6 months and remained protective for up to 8 months, with no evidence it blunted response to further vaccination, an Australian study found.

SPONSORED CONTENT
October 10, 2023
1 min read
Save

IDWeek returns with relaxed COVID-19 policies

IDWeek returns with relaxed COVID-19 policies

IDWeek relaxed its COVID-19 policies this year, no longer requiring that attendees wear a mask or provide proof of vaccination.

SPONSORED CONTENT
October 09, 2023
3 min read
Save

Prenatal COVID-19, maternal stress could affect infants’ attention span

Prenatal COVID-19, maternal stress could affect infants’ attention span

An NIH-funded study found a potential link between the combination of prenatal COVID-19 and maternal stress and an increased risk for impaired attention span in infants, according to findings reported in Pediatric Research.

SPONSORED CONTENT
October 09, 2023
2 min read
Save

Cancer center’s anti-COVID efforts reduced nosocomial infections

Cancer center’s anti-COVID efforts reduced nosocomial infections

Enhanced infection prevention and control efforts during COVID-19 reduced the rates of some hospital infections at a comprehensive cancer center, including Clostridioides difficile and multidrug-resistant infections, according to a study.

SPONSORED CONTENT
October 05, 2023
3 min read
Save

RSV more severe than COVID-19, flu in older adults, CDC data show

RSV more severe than COVID-19, flu in older adults, CDC data show

Fewer old adults are hospitalized with respiratory syncytial virus than COVID-19 or influenza, but those who are experience more serious outcomes than patients hospitalized with the other two illnesses, new CDC data show.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails